Home  |  Contact

UniProtKB/Swiss-Prot Q9Y6H5: Variant p.Val44Ala

Synphilin-1
Gene: SNCAIP
Variant information

Variant position:  44
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  Polymorphism
The variants are classified into three categories: Disease, Polymorphism and Unclassified.
  • Disease: Variants implicated in disease according to literature reports.
  • Polymorphism: Variants not reported to be implicated in disease.
  • Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:  From Valine (V) to Alanine (A) at position 44 (V44A, p.Val44Ala).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and hydrophobic (V) to small size and hydrophobic (A)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  0
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  44
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  919
The length of the canonical sequence.

Location on the sequence:   SLKTIPELCRRCDTQNEDRS  V SSSSWNCGISTLITNTQKPT
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         SLKTIPELCRRCDTQNEDRSVSSSSWNCGISTLITNTQKPT

Mouse                         SLKTIPALCRRCDSQNEDRSVSSSGWNCGVSTLITNPQKPT

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 919 Synphilin-1
Alternative sequence 1 – 366 Missing. In isoform 2 and isoform 5.


Literature citations

Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions.
Engelender S.; Kaminsky Z.; Guo X.; Sharp A.H.; Amaravi R.K.; Kleiderlein J.J.; Margolis R.L.; Troncoso J.C.; Lanahan A.; Worley P.F.; Dawson V.L.; Dawson T.M.; Ross C.A.;
Nat. Genet. 22:110-114(1999)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); INTERACTION WITH SNCA; SUBCELLULAR LOCATION; TISSUE SPECIFICITY; VARIANT ALA-44;

Identification and characterization of alternatively spliced form of human synphilin-1.
Lim M.K.; Ohsawa Y.; Kawamura T.; Asakawa S.; Takayanagi A.; Minoshima S.; Shimizu N.;
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 4 AND 6); VARIANT ALA-44;

Genetic association study of synphilin-1 in idiopathic Parkinson's disease.
Myhre R.; Klungland H.; Farrer M.J.; Aasly J.O.;
BMC Med. Genet. 9:19-19(2008)
Cited for: VARIANTS ALA-44; CYS-621 AND GLN-706; LACK OF ASSOCIATION WITH PARKINSON DISEASE;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.